APWM
ARNA

Atlas Private Wealth Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Atlas Private Wealth Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-545
Closed -$34K – 498
2020
Q2 		$34K Hold
545
– – 0.03% 222
2020
Q1 		$23K Hold
545
– – 0.02% 240
2019
Q4 		$25K Buy
+545
New +$25.8K 0.02% 268

Other funds holding ARNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Atlas Private Wealth Management's ARNA Position: Q3 2020 in Review

Atlas Private Wealth Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2020, closing a stake of 545 shares — an estimated $34K sold.

Atlas Private Wealth Management first reported a position in ARNA in Q4 2019 and held it in 3 quarters. The position peaked at $34K in Q2 2020. 253 funds tracked by Wall St. Rank hold ARNA as of Q3 2020.

  • Atlas Private Wealth Management reported no remaining Arena Pharmaceuticals Inc position as of Q3 2020 after selling out during the quarter.
  • Atlas Private Wealth Management sold 545 Arena Pharmaceuticals Inc shares in Q3 2020, an estimated $34K.
  • Atlas Private Wealth Management first reported a position in Arena Pharmaceuticals Inc in Q4 2019 and held it in 3 quarters.
  • Atlas Private Wealth Management's Arena Pharmaceuticals Inc position peaked at $34K in Q2 2020.
  • 253 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2020.

Based on Atlas Private Wealth Management's 13F filing for Q3 2020, filed 5 Nov 2020.